BioCryst, Idera drop merger plans

BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) said it terminated its merger agreement with Idera Pharmaceuticals Inc. (NASDAQ:IDRA) after BioCryst stockholders failed to approve the merger in a special meeting held on July 10...